6
Oct
2026

Shanghai Xinhuanghe Pharmaceutical Co.,

Exhibitor at CPHI Milan 2026 stand 14G40, Finished Dosage & Formulation
About Us

Shanghai Xinhuaghe is 100% owned subsidary  of Shanghai Chenpon. (www.chenpon.com/en)
About Chenpon:

Ø  A dynamic pharmaceutical company with over 38 commercialized products registering/supplying in 24 countries, strong sales coverage in China.

Ø  Successfully registered and exported Parecoxib Sodium for Injection—the first generic in Europe—to multiple countries.

Ø  Developed our proprietary Dry Powder Inhaler (DPI) platform, a technology commercialized by fewer than five companies worldwide.

Ø  Preparing to launch Budesonide/Fo...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
  • 86-13651842471
  • Website
  • No. 1633, Maixin Highway, , Xinqiao Town, , Songjiang District, SH 201612, Shanghai, Shanghai, China
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 14G40, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

Shanghai Xinhuanghe Pharmaceutical Co., Resources (1)